The identification and validation of a correlate of protection would expedite the clinical evaluation and regulatory approval process for existing vaccines for new populations, for vaccine regimen modifications, and for new vaccines. Team §, Coronavirus Vaccine Prevention Network (CoVPN)/Coronavirus Efficacy (COVE) Team §, and United States Government (USG)/CoVPN Biostatistics Team § +41 authors +39 authors +34 authors fewer Authors Info & AffiliationsĬorrelates of protection, which are immunological markers that can be used to reliably predict the level of vaccine efficacy against a clinically relevant end point, such as COVID-19 ( 10– 12), are highly sought in vaccine research. Koup, Immune Assays Team §, Moderna, Inc. ![]() Carpp, Rolando Pajon, Dean Follmann, Ruben O. Baden, Mira Baron, Luis De La Cruz, Cynthia Gay, Spyros Kalams, Colleen F. Hejazi, Chuong Huynh, Jacqueline Miller, Hana M. Lin, Sarah O’Connell, Charlene McDanal, Amanda Eaton, Marcella Sarzotti-Kelsoe, Yiwen Lu, Chenchen Yu, Bhavesh Borate, Lars W. Houchens, Karen Martins, , Lakshmi Jayashankar, Flora Castellino, Britta Flach, Bob C. ![]() ![]() McDermott, Youyi Fong, , David Benkeser, Weiping Deng, Honghong Zhou, Christopher R.
0 Comments
Leave a Reply. |